Q32 Bio
(NASDAQ) QTTB
Q32 Bio Financials at a Glance
Market Cap
$86.31M
Revenue (TTM)
$53.74M
Net Income (TTM)
$29.82M
EPS (TTM)
$2.30
P/E Ratio
2.57
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$5.90
Volume
1,294
Open
$7.01
Price
$5.90
Volume
1,294
Open
$7.01
Previous Close
$5.90
Daily Range
$5.66 - $7.49
52-Week Range
$1.34 - $8.04
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$5.90
Volume
1,294
Open
$7.01
Previous Close
$5.90
Daily Range
$5.66 - $7.49
52-Week Range
$1.34 - $8.04
QTTB News
QTTB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Q32 Bio
Industry
Biotechnology
Sector
Health CareEmployees
24
CEO
Jodie P. Morrison
Website
www.q32bio.comHeadquarters
Waltham, MA 02451, US
QTTB Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
31%
Net Income Margin
55%
Return on Equity
125%
Return on Capital
34%
Return on Assets
48%
Earnings Yield
38.91%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$86.31M
Shares Outstanding
14.63M
Volume
1.29K
Short Interest
0.00%
Avg. Volume
222.12K
Financials (TTM)
Gross Profit
$53.35M
Operating Income
$16.90M
EBITDA
$17.29M
Operating Cash Flow
$24.19M
Capital Expenditure
$2.00K
Free Cash Flow
$24.18M
Cash & ST Invst.
$48.30M
Total Debt
$15.34M
Q32 Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$53.74M
N/A
Gross Profit
$53.65M
+44805.8%
Gross Margin
99.83%
N/A
Market Cap
$86.31M
N/A
Market Cap/Employee
$3.08M
N/A
Employees
28
N/A
Net Income
$57.73M
+506.9%
EBITDA
$45.88M
+583.8%
Quarterly Fundamentals
Net Cash
$37.12M
-37.2%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$4.94M
-67.5%
Short Term Debt
$6.24M
+68.1%
Return on Assets
48.27%
N/A
Return on Invested Capital
33.52%
N/A
Free Cash Flow
$6.18M
+45.9%
Operating Cash Flow
$6.18M
+45.9%